Trials / Completed
CompletedNCT04119765
Plasma Oxalate in Patient With Short Bowel
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 47 (actual)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Hyperoxaluria due to fat malabsorption is seen in patients suffering from short bowel and can lead to stones and nephrocalcinosis. Not all patients are prone to these renal complications. only urinary oxaluria is measured in practice. Plasma oxalate shouldn't increase theoretically in these patients. However recent report showed an increase of plasma oxalate in patient with enteric hyperoxaluria. The aim of this study is to assess the plasma oxalate distribution in this specific population to have a new tool to predict renal complication of these patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Blood sampling | blood sampling will be used to perform oxalemia and FGF23 quantitative analysis |
| BIOLOGICAL | Urine sampling | urine sampling will be used to measure glycolate urinary rate (glycolaturia) and to perform urinary inflammation markers quantitative analysis |
| PROCEDURE | Pulse Wave Velocity (PWV) measurement | PWV will be measured thank to the Complior® device |
| PROCEDURE | central pressure measurement | central pressure will be measured thank to the Complior® device |
Timeline
- Start date
- 2020-02-27
- Primary completion
- 2022-05-04
- Completion
- 2022-05-04
- First posted
- 2019-10-08
- Last updated
- 2022-07-21
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04119765. Inclusion in this directory is not an endorsement.